Table 2.
The mean scores of the EORTC QOL scales in different periods of time.
| T1 scores (± SD) | T2 scores (± SD) | T3 scores (± SD) | |
|---|---|---|---|
| EORTC QLQ-30 | |||
| Global quality of life | 51 (± 22) | 58 (± 20) | 60 (± 22) |
| Physical functioning | 73 (± 24) | 80 (± 21) | 87 (± 15) |
| Emotional functioning | 72 (± 26) | 78 (± 23) | 79 (± 24) |
| Cognitive functioning | 78 (± 24) | 75 (± 20) | 77 (± 19) |
| Social functioning | 59 (± 35) | 65 (± 29) | 72 (± 32) |
| Role functioning | 75 (± 34) | 80 (± 31) | 88 (± 23) |
| Fatigue | 41 (± 27) | 27 (± 26) | 25 (± 23) |
| Nausea/vomiting | 10 (± 19) | 03 (± 13) | 04 (± 11) |
| Pain | 35 (± 31) | 18 (± 22) | 14 (± 20) |
| Dyspnea | 15 (± 23) | 15 (± 22) | 15 (± 23) |
| Insomnia | 35 (± 36) | 24 (± 30) | 26 (± 30) |
| Appetite loss | 28 (± 32) | 13 (± 22) | 11 (± 19) |
| Constipation | 17 (± 22) | 17 (± 27) | 12 (± 19) |
| Diarrhea | 13 (± 23) | 7 (± 15) | 10 (± 17) |
| Financial problems | 46 (± 39) | 44 (± 35) | 36 (± 36) |
| EORTC QLQ-H&N35 | |||
| Pain | 29 (± 26) | 18 (± 24) | 12 (± 14) |
| Swallowing | 45 (± 28) | 38 (± 25) | 44 (± 26) |
| Senses (taste/smell) | 30 (± 29) | 32 (± 33) | 17 (± 27) |
| Speech | 34 (± 29) | 29 (± 28) | 35 (± 30) |
| Social eating | 48 (± 30) | 42 (± 31) | 47 (± 34) |
| Social contact | 26 (± 27) | 22 (± 25) | 27 (± 28) |
| Sexuality | 33 (± 34) | 29 (± 32) | 24 (± 28) |
| Teeth | 33 (± 37) | 42 (± 41) | 44 (± 34) |
| Opening mouth | 49 (± 35) | 47 (± 36) | 54 (± 40) |
| Dry mouth | 48 (± 37) | 53 (± 35) | 48 (± 34) |
| Sticky saliva | 50 (± 35) | 34 (± 33) | 33 (± 35) |
| Coughing | 33 (± 30) | 31 (± 23) | 26 (± 25) |
| Feeling ill | 45 (± 35) | 26 (± 26) | 21 (± 25) |
T1, within the first year after treatment beginning; T2, post-treatment 1−3 years; T3, post-treatment 3 years and thereafter.
EORTC, European Organization for Research and Treatment of Cancer; QLQ, quality of life; H&N, head and neck; SD, standard deviation.